首页> 外文期刊>Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases >Development of macrolide resistance by ribosomal protein L4 mutation in Streptococcus pyogenes during miocamycin treatment of an eight-year-old Greek child with tonsillopharyngitis.
【24h】

Development of macrolide resistance by ribosomal protein L4 mutation in Streptococcus pyogenes during miocamycin treatment of an eight-year-old Greek child with tonsillopharyngitis.

机译:化脓性链球菌核糖体蛋白L4突变对米卡霉素治疗8岁希腊扁桃体咽炎儿童的过程中大环内酯类耐药性的发展。

获取原文
获取原文并翻译 | 示例
       

摘要

Streptococcus pyogenes isolates with the same pulsed-field patterns were recovered from the throat cultures of a child with tonsillopharyngitis before and after treatment with miocamycin, a 16-membered macrolide. The initial isolate was macrolide-susceptible, but the isolates after the treatment were resistant to 14 and 15-membered macrolides and had two amino acid (65WR66) deletions in ribosomal protein L4.
机译:化脓性链球菌分离株具有相同的脉冲场模式,是从儿童扁桃体咽炎的咽喉培养物中回收的,并用米卡霉素(一种16元大环内酯)治疗前后。最初的分离株易感大环内酯类,但处理后的分离株对14和15元大环内酯类耐药,并在核糖体蛋白L4中具有两个氨基酸(65WR66)缺失。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号